AG˹ٷ

STOCK TITAN

Dzéܳ Develops Game Changing Quality Control Solution GENE-UP® PRO HRM

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Dzéܳ (OTC:BMXXY) has launched GENE-UP® PRO HRM, the first DNA-based test for detecting heat-resistant molds at the molecular level. Developed in partnership with Ocean Spray Cranberries, this innovative solution reduces testing time from 15 days to just 72 hours, offering significant operational benefits for juice and concentrate manufacturers.

The new test provides validated equivalency to the CMMEF Ch22 Reference Method while delivering faster results, helping manufacturers reduce storage costs and protect brand reputation. When used alongside GENE-UP® PRO ACB, the solution offers comprehensive quality control for beverage spoilage concerns.

Dzéܳ (OTC:BMXXY) ha lanciato GENE-UP® PRO HRM, il primo test basato sul DNA per rilevare muffe resistenti al calore a livello molecolare. Sviluppata in collaborazione con Ocean Spray Cranberries, questa soluzione innovativa riduce i tempi di analisi da 15 giorni a soli 72 ore, offrendo vantaggi operativi significativi per i produttori di succhi e concentrati.

Il nuovo test garantisce equivalenza validata con il Metodo di Riferimento CMMEF Ch22, fornendo risultati più rapidi che aiutano i produttori a ridurre i costi di stoccaggio e a proteggere la reputazione del marchio. Utilizzato insieme a GENE-UP® PRO ACB, la soluzione assicura un controllo qualità completo contro i problemi di deterioramento delle bevande.

Dzéܳ (OTC:BMXXY) ha lanzado GENE-UP® PRO HRM, la primera prueba basada en ADN para detectar mohos resistentes al calor a nivel molecular. Desarrollada en colaboración con Ocean Spray Cranberries, esta innovadora solución reduce el tiempo de análisis de 15 días a solo 72 horas, ofreciendo importantes beneficios operativos para los fabricantes de jugos y concentrados.

La nueva prueba ofrece equivalencia validada con el Método de Referencia CMMEF Ch22, proporcionando resultados más rápidos que ayudan a los fabricantes a reducir costos de almacenamiento y proteger la reputación de la marca. Utilizada junto con GENE-UP® PRO ACB, la solución brinda un control de calidad integral para problemas de deterioro en bebidas.

Dzéܳ (OTC:BMXXY)� 분자 수준에서 내열� 곰팡이를 감지하는 최초� DNA 기반 검사인 GENE-UP® PRO HRM� 출시했습니다. Ocean Spray Cranberries와 협력하여 개발� � 혁신적인 솔루션은 검� 시간� 15일에� � 72시간으로 단축하여 주스 � 농축� 제조업체� � 운영� 이점� 제공합니�.

새로� 검사는 CMMEF Ch22 참조 방법� 검증된 동등성을 제공하며, � 빠른 결과� 통해 제조업체가 저� 비용� 줄이� 브랜� 평판� 보호� � 있도� 돕습니다. GENE-UP® PRO ACB와 함께 사용하면 음료 부� 문제� 대� 포괄적인 품질 관리를 제공합니�.

Dzéܳ (OTC:BMXXY) a lancé GENE-UP® PRO HRM, le premier test basé sur l’ADN permettant de détecter les moisissures résistantes à la chaleur au niveau moléculaire. Développée en partenariat avec Ocean Spray Cranberries, cette solution innovante réduit le temps d’analyse de 15 jours à seulement 72 heures, offrant des avantages opérationnels importants pour les fabricants de jus et de concentrés.

Le nouveau test garantit une équivalence validée avec la méthode de référence CMMEF Ch22 tout en fournissant des résultats plus rapides, aidant ainsi les fabricants à réduire les coûts de stockage et à protéger la réputation de leur marque. Utilisée conjointement avec GENE-UP® PRO ACB, la solution assure un contrôle qualité complet face aux problèmes de détérioration des boissons.

Dzéܳ (OTC:BMXXY) hat GENE-UP® PRO HRM eingeführt, den ersten DNA-basierten Test zur molekularen Erkennung hitzeresistenter Schimmelpilze. In Zusammenarbeit mit Ocean Spray Cranberries entwickelt, verkürzt diese innovative Lösung die Testdauer von 15 Tagen auf nur 72 Stunden und bietet Herstellern von Säften und Konzentraten erhebliche betriebliche Vorteile.

Der neue Test bietet eine validierte Gleichwertigkeit zur CMMEF Ch22 Referenzmethode und liefert schnellere Ergebnisse, die Herstellern helfen, Lagerkosten zu senken und den Markenruf zu schützen. In Kombination mit GENE-UP® PRO ACB bietet die Lösung eine umfassende Qualitätskontrolle bei Problemen mit Getränkebeschädigungen.

Positive
  • Reduces testing time from 15 days to 72 hours, significantly improving operational efficiency
  • Helps manufacturers reduce storage costs and inventory holding time
  • Provides validated equivalency to industry standard reference method
  • Can be implemented alongside existing GENE-UP® PRO ACB for comprehensive quality control
Negative
  • None.

DNA-Based Heat Resistant Mold Test Delivers Deeper Diagnostics in a Fraction of the Time, On-Site Solution is Now Available for Implementation

CHICAGO, Aug. 5, 2025 /PRNewswire/ --, a world leader in the field of in vitro diagnostics, is pleased to announce the launch of GENE-UP® PRO HRM—the first DNA-based test commercially developed to detect heat-resistant molds at the molecular level.

Developed in partnership with historic brand Cranberries, Inc., the game-changing testing innovation can accurately identify the presence of viable heat-resistant molds with validated equivalency to the CMMEF Ch22 Reference Method. GENE-UP® PRO HRM also provides a significantly shorter time-to-result, reducing the current Compendial Method 15-day result time down to only 72 hours.

The lengthy Compendial Method 15-day time-to-result forces juice and concentrate producers to decide between incurring costly storage fees until test results are received or forgoing the waiting period and risk shipping spoilage-prone products. The reduced time-to-result with GENE-UP® PRO HRM fuels improved operational efficiencies, minimizes manufacturer storage costs, and safeguards brand reputation among consumers.

"Dzéܳ is a longstanding diagnostic partner of the beverage industry, and we're always up for the challenge of solving our customer's toughest spoilage problems," said Ben Pascal, global head of the xPRO� Program at Dzéܳ. "We embraced the opportunity to partner with Ocean Spray to create a custom microbiology quality control test that had broader implications for all juice and concentrate manufacturers."

While typically posing no public health or safety risk, in recent years heat-resistant molds have become a top quality concern and operational bottleneck for beverage and concentrate manufacturers. Unlike other yeast and mold test kits in the market, GENE-UP® PRO HRM is an innovative and complete testing solution that targets ascospore profiles to ultimately determine the presence of viable heat-resistant molds, resulting in the most comprehensive and reliable testing solution available today.

"Our loyal consumers have come to trust the high quality of our products and the integrity of our brand," notes Chris McNamara, Ocean Spray FSQA Senior Manager. "As the juice industry has evolved over the years, so has the risk profile for spoilage concerns. As a farmer-owned cooperative, innovation is in our DNA. Partnering with Dzéܳ resulted in the development of a cutting-edge quality control solution with benefits not just for Ocean Spray but the industry at large."

GENE-UP® PRO HRM can be implemented alongside Dzéܳ's GENE-UP® PRO ACB, a real-time PCR assay that detects and predicts spoilage due to Alicyclobacillus, causing off flavors and aromas in finished juice products. Together, the offering collectively speeds up and boosts confidence in the quality process across all major beverage spoilage concerns while also reducing costs and improving yield. Both GENE-UP® PRO HRM and GENE-UP® PRO ACB are a result of Dzéܳ's xPROProgram, an innovation engine within Dzéܳ that challenges the status quo to advance molecular diagnostics.

To learn more about how GENE-UP® PRO HRM, GENE-UP® PRO ACB, or Dzéܳ's other game-changing xPRO� solutions can unlock operational efficiencies and cost savings, please visit .

ABOUT BIOMÉRIEUX
Pioneering Diagnostics
A world leader in the field of ٰ diagnostics since 1963, Dzéܳ is present in 45countries and serves more than 160countries with the support of a large network of distributors. In 2024, revenues reached �4Dz, with over 93% of sales outside of France.

Dzéܳ provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
.

Dzéܳ is listed on the Euronext Paris stock market.
Symbol: BIM � ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP

CONTACTS

INVESTORS RELATIONS



Dzéܳ



Aymeric Fichet



Tel: +33 (0)4 78 87 20 00



[email protected]






MEDIA RELATIONS



Dzéܳ

Dzéܳ

United States

Romain Duchez

Maggie DiSantis

Samantha Flynn (JUNIPR)

Tel: +33 (0)4 78 87 20 00

Tel: (331) 385 1332

Tel: (717) 413 0370

[email protected]

[email protected]

[email protected]




Cision View original content to download multimedia:

SOURCE Dzéܳ

FAQ

What is Dzéܳ's GENE-UP® PRO HRM and how does it work?

GENE-UP® PRO HRM is the first commercial DNA-based test that detects heat-resistant molds at the molecular level by targeting ascospore profiles, providing results in 72 hours compared to traditional 15-day methods.

How much faster is GENE-UP® PRO HRM compared to traditional testing methods?

GENE-UP® PRO HRM delivers results in 72 hours, reducing the traditional Compendial Method time-to-result by 12 days from the standard 15-day waiting period.

What benefits does GENE-UP® PRO HRM offer to juice manufacturers?

The solution helps manufacturers reduce storage costs, improve operational efficiencies, minimize the risk of shipping spoilage-prone products, and protect brand reputation through faster quality control testing.

Can GENE-UP® PRO HRM be used with other Dzéܳ testing solutions?

Yes, it can be implemented alongside GENE-UP® PRO ACB, a real-time PCR assay that detects Alicyclobacillus, providing comprehensive quality control for beverage spoilage concerns.

Who developed GENE-UP® PRO HRM and when was it launched?

GENE-UP® PRO HRM was developed by Dzéܳ in partnership with Ocean Spray Cranberries, Inc., and launched in August 2025.
Biomerieux

OTC:BMXXY

BMXXY Rankings

BMXXY Latest News

BMXXY Stock Data

16.72B
44.60M
Diagnostics & Research
Healthcare
France
Ѳ-'ÉٴǾ